Mounjaro or wegovy?
Which one is better
What They Are
Mounjaro (tirzepatide) — a dual GIP + GLP-1 receptor agonist. It works on two hormone pathways to improve insulin secretion and reduce appetite.
Ozempic (semaglutide) — a GLP-1 only receptor agonist that boosts insulin release, slows gastric emptying, and suppresses hunger.
Both are once-weekly injections used to treat type 2 diabetes and help with weight loss, though Ozempic’s higher-dose version (Wegovy) is specifically approved for weight management.
📊 Effectiveness: Blood Sugar & Weight Loss
📈 Blood Sugar (HbA1c)
Mounjaro generally shows greater reduction in HbA1c compared with Ozempic.
Some trials report tirzepatide lowering HbA1c more than semaglutide across doses.
🏃♂️ Weight Loss
Mounjaro tends to cause greater weight loss on average than Ozempic.
In head-to-head comparisons, Mounjaro led to larger average weight reduction. �
Drugs.com
This is likely because Mounjaro targets two incretin pathways vs semaglutide only targeting one.
➡ Summary: If your main goals are sizable weight loss and stronger blood sugar control, Mounjaro often shows better results than Ozempic.
